NYSE · NVO
Novo Nordisk A/S (NVO)
$39.22+$1.10 (+2.89%)as of 4:00 PM ET Thu 15 Oct
Live quote as of 4:00 PM ET Thu 15 Oct · previous close $38.12 · source: Finnhub
Annual revenue
$309.1B
+6.4% vs. a year earlier · Year ended 31 Dec 2025
YTD -22.9%1M -6.0%Mkt cap $173.7B52-wk range $35.29–$63.98
What happened
- Novo Nordisk closed at $39.22 on Thursday, 15 October, up 2.89%. It is down 22.9% this year, 38.7% below its 52-week closing high.
- In pre-market trading it was at $39.27 (+0.13%) at 8:07 AM ET.
- Its latest reported year (year ended 31 Dec 2025) showed revenue of $309.1B, up 6% from $290.4B, and net income of $102.4B.
- Next earnings: Wednesday, 4 November (estimated date); consensus EPS $0.81.
NVO price chart
$40$45$50AugSepOct$39.22
$40$45$50MayJunJulAugSepOct$39.22
$40$50$60NovDecJan '26FebMarAprMayJunJulAugSepOct$39.22
Key numbers
| Revenue (latest year) | $309.1B+6.4% year over year · Year ended 31 Dec 2025 |
|---|---|
| Net income | $102.4Bup 1% from $101.0B a year earlier |
| Diluted EPS | $23.03vs. $22.63 a year earlier |
| Cash & equivalents | $26.5Bat 31 Dec 2025 |
| Market cap | $173.66BNasdaq |
| 52-week closing range | $35.29 – $63.98high on 26 Jan 2026 |
| Latest periodic report | 20-Ffiled 4 Feb 2026 · period 31 Dec 2025 |
| Next earnings | 4 Nov 2026*estimated (Zacks via Nasdaq) |
| Industry | Biotechnology: Pharmaceutical PreparationsHealth Care |
Revenue by year
In the filing
Novo Nordisk's latest 20-F, filed 4 February 2026 for the period ended 31 December 2025, reported revenue of $309.1B, up 6% from $290.4B a year earlier.
Net income was $102.4B (up from $101.0B). Diluted EPS was $23.03, against $22.63 a year before. Cash and equivalents stood at $26.5B on 31 Dec 2025.
Earnings vs. expectations
Reported EPS Consensus
Recent SEC filings
| Date | Form | What it is |
|---|---|---|
| 13 Oct 2026 | 6-K | Report of a foreign issuer |
| 6 Oct 2026 | 6-K | Report of a foreign issuer |
| 5 Oct 2026 | 6-K | Report of a foreign issuer |
| 28 Sep 2026 | 6-K | Report of a foreign issuer |
| 21 Sep 2026 | 6-K | Report of a foreign issuer |
| 17 Sep 2026 | 6-K | Report of a foreign issuer |
| 15 Sep 2026 | 6-K | Report of a foreign issuer |
| 9 Sep 2026 | 6-K | Report of a foreign issuer |
The daily filings brief
Before the US open: the movers, the SEC filings and the earnings that matter. Free, one short email per US trading day.
We only use your email to send the brief.